Search

everythinglearnresearchcommunity

for

Search:↓

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

New techniques in hair restoration surgery can fix unnatural results from old methods, improving patient self-esteem.

Palmitoyl tetrapeptide-20 may help reduce hair greying and increase melanin production.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

The study created a new method to test drugs that affect hormone processing in skin.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

Androgens and estrogens are crucial for insulin secretion in males.

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

TRPV4 helps cells repair tissue and reduce scarring by controlling calcium levels.

The herbal hair serum is effective and safe for promoting hair growth and reducing hair loss.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

The interdisciplinary approach improved the quality of life for a Parkinson's patient and eased staff workload.

The two-factor model fits better for Chinese patients' understanding of illness causes than the original four-factor model.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.

Impulsiveness is common across various psychiatric disorders and linked to many psychological symptoms.

Thyroid function affects skin health, with a complex interaction between the two.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Plants change their growth in response to shade based on light signals detected by phytochrome.

Hair loss in men aged 25-44 may be linked to gum disease.

Hair cortisol may be a good indicator of recent mood in people with bipolar disorder.

Adding value and variety to herbal products helps promote them and can make India a leading exporter.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.